One study found that ALKBH5 can affect the tumor microenvironment of colorectal cancer, thus mediating the resistance of colorectal cancer patients to the anti-PD-1 therapy response (Li et al., 2020b). The gene discussed is PDCD1; the disease is colorectal cancer.